Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase 1
Ligand
BDBM50437407
Substrate
n/a
Meas. Tech.
IMAP-FP Assay
IC50
0.2045±n/a nM
Citation
Lim, J; Kelley, EH; Methot, JL; Zhou, H; Petrocchi, A; Mansoor, UF; Fischer, C; O'Boyle, B; Guerin, DJ; Bienstock, CE; Boyce, CW; Daniels, MH; Falcone, D; Ferguson, RD; Fevrier, S; Huang, X; Lipford, KA; Sloman, DL; Wilson, K; Zhou, W; Witter, D; Maletic, MM; Siliphaivanh, P Compounds that are ERK inhibitors US Patent US9023865 Publication Date 5/5/2015
More Info.:
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Human
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS